Similar Items: Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases
- Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
- Ketamine reduces the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats
- Discovery of a chemical small molecule inducing umbilical cord mesenchymal stem cell differentiation to vascular endothelial cells
- Assessing Evidence to Include Filifactor alocis as a Novel Candidate in Socransky's Complexes
- JNK inhibitors: is there a future?
- ACSS2-mediated lysine crotonylation attenuates senescence and enhances the therapeutic efficacy of adipose-derived stem cells in inflammatory bowel disease